Quick Answer
STANDARD BIOTOOLS INC. reported Total Revenue of $85.33 million for fiscal year 2025.
STANDARD BIOTOOLS INC. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $85.33M | -6.2% |
| 2024 | $91.01M | -14.4% |
| 2023 | $106.34M | +8.6% |
| 2022 | $97.95M | -25.0% |
| 2021 | $130.58M | -5.5% |
| 2020 | $138.14M | +17.8% |
| 2019 | $117.24M | +3.8% |
| 2018 | $112.96M | +10.8% |
| 2017 | $101.94M | -2.4% |
| 2016 | $104.45M | -8.9% |
| 2015 | $114.71M | -1.5% |
| 2014 | $116.46M | +63.6% |
| 2013 | $71.18M | +36.0% |
| 2012 | $52.33M | +22.1% |
| 2011 | $42.87M | +27.7% |
| 2010 | $33.56M | +32.1% |
| 2009 | $25.41M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $19.55M | -11.5% | -10.2% |
| June 30, 2025 | $21.76M | -3.2% | -46.7% |
| March 31, 2025 | $40.80M | -10.4% | +84.7% |
| September 30, 2024 | $22.09M | -12.9% | -1.8% |
| June 30, 2024 | $22.49M | -18.7% | -50.6% |
| March 31, 2024 | $45.54M | +81.3% | +79.5% |
| September 30, 2023 | $25.37M | -1.1% | -8.3% |
| June 30, 2023 | $27.67M | +47.3% | +10.1% |
- STANDARD BIOTOOLS INC. showed a decrease of -6.2% in Total Revenue compared to the prior fiscal year.
- Over the 2009–2025 period, STANDARD BIOTOOLS INC.’s total revenue has grown by 235.8% (from $25.41 million to $85.33 million).
- The most recent figure is from STANDARD BIOTOOLS INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: